Various private equity investors as well as strategic investors who are keen to acquire healthcare assets in the market are surprised as the valuation has shot up in a short span of time.
By Bhawna Gupta
NewRise is in final stages of completing its Gurgaon hospital
Shares of healthcare firms Alkem Laboratories Ltd and Dr Lal Pathlabs Ltd, opened 31.43% and 30.4% higher from their respective issue price of Rs.1,050 and Rs.550 per share, following their successful initial public offering (IPO) earlier this month. Shares of Alkem Lab opened at Rs.1,380 and touched a high ofRs.1,401.40… Read more »
The initial public offer (IPO) of Bengaluru-based heatlhcare services provider Narayana Hrudayalaya was subscribed only 30 per cent on the second day, as per a report in PTI. The Rs 613-crore IPO received bids for 51,12,900 shares against the total issue size of 1,71,66,309 shares, data available with the NSE… Read more »
Investors have lapped up shares on offer from healthcare firms, two of whom closed their initial public offerings (IPOs) on Thursday, as they seek to gain greater exposure to the rapidly growing sector. The positive investor sentiment could help upcoming issues, including a Rs.613 crore share sale by the Devi… Read more »
Drug maker Alkem Laboratories Ltd and healthcare firms Narayana Hrudayalaya and Dr Lal Pathlabs are planning to launch their initial public offerings (IPOs) in the first half of December to collectively raise over Rs.2,500 crore ($377 million), according to several people aware of the development. While Alkem is looking to raise… Read more »